7Asensio C ,Jimenez M ,Ktihne F,et al. The lack of 13-adrenoceptors results in enhanced insulin sensitivity in mice exhibiting increased adiposity and glucose intolerance[ J ]. Diabetes, 21305,54(12) :3490-3495.
8Himms-Hagen J, Melnyk A, Zingaretti MC, et al. Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adi- pocytes[J]. American Journal of Physiology-Cell Physiology, 2000, 279 ( 3 ) : C670-C681.
9Brondani LA, Assmann TS, Duarte GK, et al. The role of the un- coupling protein 1 ( UCP1 ) on the development of obesity and type 2 diabetes mellitus [ J ]. Arquivos Brasileiros de Endocrinologia & Metabologia, 2012, 56(4) : 215-225.
10Valet P, Grujic D, Wade J, et al. Expression of human a2-adrenergic receptors in adipose tissue of b3-adrenergic receptor-deficient mice promotes diet-induced obesity [ J ]. Journal of Biological Chemistry, 2000, 275 (44) : 34797-34802.
6[10]Kaumann AJ, and Molenaar P. Differences between the third cardiac b-adrenoceptor and the colonic β 3-adrenoceptor in the rat. Br J prarmacol, 1996; 118: 2085～ 2098
7[11]Surwit RS, Dixon TM, Petro AE, et al. Diazoxide restores beta3-adrenergic receptor function in diet-induced obesity and diabetes. Endocrinology, 2000 Oct; 141(10) :3630～7.
8[12]Fisher MH, Amend AM, Bach Tj, Barker JM, et al. A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J Clin Invest, 1998 Jun 1;101(11) :2387～93.
9[13]Nicholls DG. A history of UCP1. Biochem Soc Trans. 2001 Nov; 29(Pt 6):751～5.
10[15]Gomez-Ambrosi J, Fruhbeck G, Martinez JA. Interactiors between an alpha2-adrenergic antagonist and a beta3-adrenergic agonist on the expression of UCP2 and UCP3 in rats. J Physiol Biochem, 2002 Mar; 58(1): 17 ～ 23.
